Inventor · disambiguated record
Peter Laivins
Also filed as: LAIVINS PETER
8 granted patents·9 pending applications·86 citations·filing 2013–2024
89Inventor score
Top patents by PatentIndex Score
17 records- 0197US9717724B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2016·Granted Aug 1, 2017·14 cites·24 claims
- 0296US10980795B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2018·Granted Apr 20, 2021·8 cites·15 claims
- 0396US9492442B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Nov 15, 2016·19 cites·30 claims
- 0495US9339497B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·17 cites·27 claims
- 0594US9364473B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·12 cites·29 claims
- 0693US11369597B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2018·Granted Jun 28, 2022·4 cites·13 claims
- 0792US9452162B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Sep 27, 2016·12 cites·35 claims
- 0889US2024226090A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 0988US2024342162A1Methods For Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 1082US12364691B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2022·Granted Jul 22, 2025·0 cites·5 claims
- 1177US2022096458A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
- 1266US2017368056A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
- 1366US2017049768A1Methods for treating pancreatic cancer using combination therapiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1464US2017065578A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1563US2018008591A1Methods for Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
- 1662US2016228428A1Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1744US2017202840A1Treatment of pancreatic cancer with liposomal irinotecanMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Laivins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →